Abiopharma

Best Air Purifiers for Homes in 2025

New Form 8-K - Qualigen Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001641172-25-016253 Size: 202 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form SCHEDULE 13G/A - Sagimet Biosciences Inc. Filed: 2025-06-24 AccNo: 0002069316-25-000001 Size: 8 KB

QIPT Investors Have Opportunity to Join Quipt Home Medical Corp. Fraud Investigation with the Schall Law Firm

New Form 6-K - GSK plc Filed: 2025-06-24 AccNo: 0001654954-25-007336 Size: 117 KB

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-06-24 AccNo: 0001225208-25-006168 Size: 4 KB

ImmunoPrecise fait progresser le vaccin universel contre la dengue, confirmant linnocuité, lactivation immunitaire et la stabilité structurelle à laide de sa plateforme LENSai™ basée sur la technologie brevetée HYFT®

OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit with the Schall Law Firm

FTRE Investors Have Opportunity to Lead Fortrea Holdings Inc. Securities Fraud Lawsuit with the Schall Law Firm

Hoth Therapeutics Notification (HOTH)

New Form 4 - DYADIC INTERNATIONAL INC Filed: 2025-06-24 AccNo: 0001437749-25-021101 Size: 6 KB

PEPG Investors Have Opportunity to Lead PepGen Inc. Securities Fraud Lawsuit with the Schall Law Firm

New Form 4 - DYADIC INTERNATIONAL INC Filed: 2025-06-24 AccNo: 0001437749-25-021100 Size: 8 KB

Fortrea, Emery Pharma와 협력해 FDA 기준에 맞춰 리팜핀 사용 가능한 DDI 연구 지원